Response to Food and Drug Administration draft guidance statement on research into the treatment of life-threatening emergency conditions using exception from informed consent: testimony of the neurological emergencies treatment trials.
Silbergleit
Robert
R
Neurological Emergencies Treatment Trials, Clinical Coordinating Center, Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA. robie@umich.edu
D035843:Biomedical Research / Q000592:standards*; D004635:Emergency Medicine; D032984:Ethics, Research; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent; D009422:Nervous System Diseases / Q000517:prevention & control*; D012151:Resuscitation; D014481:United States; D014486:United States Food and Drug Administration